These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Mechanism of how carbamylation reduces albumin binding to FcRn contributing to increased vascular clearance. Yadav SPS; Sandoval RM; Zhao J; Huang Y; Wang E; Kumar S; Campos-Bilderback SB; Rhodes G; Mechref Y; Molitoris BA; Wagner MC Am J Physiol Renal Physiol; 2021 Jan; 320(1):F114-F129. PubMed ID: 33283642 [TBL] [Abstract][Full Text] [Related]
9. The Role of Nonenzymatic Post-translational Protein Modifications in Uremic Vascular Calcification. Lim K; Kalim S Adv Chronic Kidney Dis; 2019 Nov; 26(6):427-436. PubMed ID: 31831121 [TBL] [Abstract][Full Text] [Related]
10. Serum Sortilin Associates With Aortic Calcification and Cardiovascular Risk in Men. Goettsch C; Iwata H; Hutcheson JD; O'Donnell CJ; Chapurlat R; Cook NR; Aikawa M; Szulc P; Aikawa E Arterioscler Thromb Vasc Biol; 2017 May; 37(5):1005-1011. PubMed ID: 28279970 [TBL] [Abstract][Full Text] [Related]
11. Sortilin mediates vascular calcification via its recruitment into extracellular vesicles. Goettsch C; Hutcheson JD; Aikawa M; Iwata H; Pham T; Nykjaer A; Kjolby M; Rogers M; Michel T; Shibasaki M; Hagita S; Kramann R; Rader DJ; Libby P; Singh SA; Aikawa E J Clin Invest; 2016 Apr; 126(4):1323-36. PubMed ID: 26950419 [TBL] [Abstract][Full Text] [Related]
12. Chronic increase of urea leads to carbamylated proteins accumulation in tissues in a mouse model of CKD. Pietrement C; Gorisse L; Jaisson S; Gillery P PLoS One; 2013; 8(12):e82506. PubMed ID: 24324801 [TBL] [Abstract][Full Text] [Related]
13. [Role of protein carbamylation in chronic kidney disease complications]. Gillery P; Jaisson S; Gorisse L; Pietrement C Nephrol Ther; 2015 Jun; 11(3):129-34. PubMed ID: 25794932 [TBL] [Abstract][Full Text] [Related]
14. Regional distribution and severity of arterial calcification in patients with chronic kidney disease stages 1-5: a cross-sectional study of the Copenhagen chronic kidney disease cohort. Sørensen IMH; Saurbrey SAK; Hjortkjær HØ; Brainin P; Carlson N; Ballegaard ELF; Kamper AL; Christoffersen C; Feldt-Rasmussen B; Kofoed KF; Bro S BMC Nephrol; 2020 Dec; 21(1):534. PubMed ID: 33297991 [TBL] [Abstract][Full Text] [Related]
15. Protein carbamylation: a key driver of vascular calcification during chronic kidney disease. Hawkins CL Kidney Int; 2018 Jul; 94(1):12-14. PubMed ID: 29933841 [TBL] [Abstract][Full Text] [Related]
16. Longitudinal Changes in Protein Carbamylation and Mortality Risk after Initiation of Hemodialysis. Kalim S; Trottier CA; Wenger JB; Wibecan J; Ahmed R; Ankers E; Karumanchi SA; Thadhani R; Berg AH Clin J Am Soc Nephrol; 2016 Oct; 11(10):1809-1816. PubMed ID: 27445162 [TBL] [Abstract][Full Text] [Related]
17. Effect of Sevelamer and Nicotinamide on Albumin Carbamylation in Patients with End-Stage Kidney Disease. Lenglet A; Rahali MA; Sauvage FL; Liabeuf S; Choukroun G; Essig M; El Balkhi S; Massy ZA Drugs R D; 2021 Jun; 21(2):231-238. PubMed ID: 34101139 [TBL] [Abstract][Full Text] [Related]
18. Elevated serum sortilin is related to carotid plaque concomitant with calcification. Huang S; Yu X; Wang H; Zheng J Biomark Med; 2020 Apr; 14(5):381-389. PubMed ID: 32077308 [No Abstract] [Full Text] [Related]
19. Chronic Kidney Disease Circulating Calciprotein Particles and Extracellular Vesicles Promote Vascular Calcification: A Role for GRP (Gla-Rich Protein). Viegas CSB; Santos L; Macedo AL; Matos AA; Silva AP; Neves PL; Staes A; Gevaert K; Morais R; Vermeer C; Schurgers L; Simes DC Arterioscler Thromb Vasc Biol; 2018 Mar; 38(3):575-587. PubMed ID: 29301790 [TBL] [Abstract][Full Text] [Related]
20. Protein carbamylation in kidney disease: pathogenesis and clinical implications. Kalim S; Karumanchi SA; Thadhani RI; Berg AH Am J Kidney Dis; 2014 Nov; 64(5):793-803. PubMed ID: 25037561 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]